Position in VTGN
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$351,546
-$55,508 QoQ
Shares Held
616,749
0.0% QoQ
Ownership
1.50%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STEMPOINT CAPITAL LP holds $493,288,963 across 62 Biotechnology names. VTGN ranks #62 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRRK |
Scholar Rock Holding Corp
|
1,035,496 | $50,904,983 | |
| 2 | ABVX |
Abivax S.A.
|
313,791 | $34,940,627 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
|
1,215,743 | $28,399,756 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
281,632 | $27,388,712 | |
| 5 | IMVT |
Immunovant, Inc.
|
746,494 | $18,542,910 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
56,267 | $18,128,664 | |
| 7 | SRZN |
Surrozen, Inc./DE
|
525,639 | $15,311,863 | |
| 8 | MBX |
MBX Biosciences, Inc.
|
499,469 | $14,909,149 |
All Filings in VTGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $351,546 | 616,749 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $407,054 | 616,749 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,834,830 | 2,488,685 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,826,508 | 2,413,254 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,916,384 | 2,366,554 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,869,050 | 2,328,492 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,558,843 | 1,846,792 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,433,064 | 1,848,582 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $9,760,512 | 1,848,582 | Shares | Sole | 2024-08-09 | |
| 2023-12-31 | $9,201,534 | 1,790,182 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||